Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.00 -2.46 (-3.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Tarsus Pharmaceuticals' Return on Capital Employed [ROCE] came in at -11.55% for Q2 2026, up 12.51 percentage points from -24.05% a year earlier and up 0.32 percentage points from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Tarsus Pharmaceuticals' Return on Capital Employed [ROCE] was -21.26%, up 28.85 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +3.34 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -50.11% in FY2024 (+18.15 pp), -68.25% in FY2023 (-34.89 pp), -33.37% in FY2022 (-25.95 pp) and -7.41% in FY2021 (+17.18 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q4 2021.
  • Year-over-year, Return on Capital Employed [ROCE] has increased for nine consecutive quarters, with an average year-over-year change of +20.51 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2025 (a gain of 27.89 percentage points), and the weakest in Q4 2023 (a drop of 33.31 percentage points).
  • Business Quant data shows TARS's Return on Capital Employed [ROCE] at -11.87% (Q1 2026), -17.20% (Q4 2025) and -21.98% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Tarsus Pharmaceuticals 3.16 Bn 2.10 Bn 161.80 Mn -11.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.55%
Mar 31, 2026 -11.87%
Dec 31, 2025 -17.20%
Sep 30, 2025 -21.98%
Jun 30, 2025 -24.05%
Mar 31, 2025 -30.96%
Dec 31, 2024 -40.73%
Sep 30, 2024 -45.25%
Jun 30, 2024 -50.20%
Mar 31, 2024 -58.86%
Dec 31, 2023 -62.25%
Sep 30, 2023 -55.39%
Jun 30, 2023 -51.67%
Mar 31, 2023 -33.03%
Dec 31, 2022 -28.93%
Sep 30, 2022 -26.96%
Jun 30, 2022 -26.72%
Mar 31, 2022 -25.30%
Dec 31, 2021 -7.02%
Sep 30, 2021 -4.92%
API Access

Tarsus Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TARS&period=max&api_key=YOUR_API_KEY